EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

19 API Suppliers, 10 USDMF, 6 JDMF, 1 EU WC, 7 Listed Suppliers, $ API Reference Price

19 API Suppliers
10 USDMF
6 JDMF
1 EU WC
7 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

131 FDF Dossiers, 15 FDA Orange Book, 77 Europe, 21 Canada, 11 South Africa, 7 Listed Dossiers

131 FDF Dossiers
15 FDA Orange Book
77 Europe
21 Canada
11 South Africa
7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;SUBCUTANEOUS - 10,000IU/ML (10,000IU/ML), INJECTABLE;SUBCUTANEOUS - 10,000IU/4ML (2,500IU/ML), INJECTABLE;SUBCUTANEOUS - 12,500IU/0.5ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 15,000IU/0.6ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 18,000IU/0.72ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 2,500IU/0.2ML (12,500IU/ML), INJECTABLE;SUBCUTANEOUS - 5,000IU/0.2ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 7,500IU/0.3ML (25,000IU/ML), INJECTABLE;SUBCUTANEOUS - 95,000IU/3.8ML (25,000IU/ML)

drugProductComposition
INJECTABLE;SUBCUTANEOUS - 10,000IU/ML (10,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 10,000IU/4ML (2,500IU/ML)
INJECTABLE;SUBCUTANEOUS - 12,500IU/0.5ML (25,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 15,000IU/0.6ML (25,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 18,000IU/0.72ML (25,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 2,500IU/0.2ML (12,500IU/ML)
INJECTABLE;SUBCUTANEOUS - 5,000IU/0.2ML (25,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 7,500IU/0.3ML (25,000IU/ML)
INJECTABLE;SUBCUTANEOUS - 95,000IU/3.8ML (25,000IU/ML)

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 3 Actylis, 1 Finar

relatedExcipients
1 Nanjing Well Pharmaceutical
3 Actylis
1 Finar

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Topical, 1 Solubilizers

excipientsByApplications
3 Parenteral
2 Topical
1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 3 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
3 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 46 Finished Drug Prices, 5 Annual Reports

globalSalesInformation
1 US Medicaid Prescriptions
46 Finished Drug Prices
5 Annual Reports

MARKET PLACE

16 APIs, 43 FDF Dossiers

marketPlace
16 APIs
43 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM , 1 USP , 1 Others

otherSolutions
2 EDQM
1 USP
1 Others

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 29,094

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

131

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

1,939,380

Annual Reports (USD Million)

1,317

Finished Drug Prices

5 RELATED EXCIPIENT COMPANIES

6EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as:

Molecular Formula

C₁₂H₁₇NO₂₀S₃-₄

Molecular Weight

591.5 g/mol

InChI Key

OHJKXVLJWUPWQG-IUYNYSEKSA-J

1 2D Structure

Dalteparin sodium

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(4S,6R)-6-[(2R,4R)-4,6-dihydroxy-5-(sulfonatoamino)-2-(sulfonatooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-5-sulfonatooxyoxane-2-carboxylate

2.1.2 InChI

InChI=1S/C12H21NO20S3/c14-4-3(13-34(20,21)22)11(19)30-2(1-29-35(23,24)25)7(4)31-12-9(33-36(26,27)28)6(16)5(15)8(32-12)10(17)18/h2-9,11-16,19H,1H2,(H,17,18)(H,20,21,22)(H,23,24,25)(H,26,27,28)/p-4/t2-,3?,4-,5?,6+,7?,8?,9?,11?,12-/m1/s1

2.1.3 InChI Key

OHJKXVLJWUPWQG-IUYNYSEKSA-J

2.1.4 Canonical SMILES

C(C1C(C(C(C(O1)O)NS(=O)(=O)[O-])O)OC2C(C(C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]

2.1.5 Isomeric SMILES

C([C@@H]1C([C@@H](C(C(O1)O)NS(=O)(=O)[O-])O)O[C@H]2C([C@H](C(C(O2)C(=O)[O-])O)O)OS(=O)(=O)[O-])OS(=O)(=O)[O-]

2.2 Create Date

2009-05-14

3 Chemical and Physical Properties

Molecular Formula	C₁₂H₁₇NO₂₀S₃-₄
Molecular Weight	591.5 g/mol
XLogP3	-5.6
Hydrogen Bond Donor Count	5
Hydrogen Bond Acceptor Count	21
Rotatable Bond Count	6
Exact Mass	590.95060545 g/mol
Monoisotopic Mass	590.95060545 g/mol
Topological Polar Surface Area	376 Å²
Heavy Atom Count	36
Formal Charge	-4
Complexity	1040
Isotope Atom Count	0
Defined Atom Stereocenter Count	4
Undefined Atom Stereocenter Count	6
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Information

1 of 4
Drug Name	Heparin sodium in plastic container
Active Ingredient	Heparin sodium
Dosage Form	Injectable
Route	Injection
Strength	10,000 units/ml; 5,000 units/ml; 20,000 units/ml; 1,000 units/ml
Market Status	Prescription
Company	Fresenius Kabi Usa

2 of 4
Drug Name	Heparin sodium preservative free
Active Ingredient	Heparin sodium
Dosage Form	Injectable
Route	Injection
Strength	10,000 units/ml; 1,000 units/ml
Market Status	Prescription
Company	Hospira; Shenzhen Techdow; Pfizer; Fresenius Kabi Usa; Sagent Pharms

3 of 4
Drug Name	Heparin sodium in plastic container
Active Ingredient	Heparin sodium
Dosage Form	Injectable
Route	Injection
Strength	10,000 units/ml; 5,000 units/ml; 20,000 units/ml; 1,000 units/ml
Market Status	Prescription
Company	Fresenius Kabi Usa

4 of 4
Drug Name	Heparin sodium preservative free
Active Ingredient	Heparin sodium
Dosage Form	Injectable
Route	Injection
Strength	10,000 units/ml; 1,000 units/ml
Market Status	Prescription
Company	Hospira; Shenzhen Techdow; Pfizer; Fresenius Kabi Usa; Sagent Pharms